News

Paediatricians have seen a huge rise in cases of anorexia nervosa and other food restriction disorders in this age group, with some reporting a doubling, tripling or even quadrupling of cases compared with the same period last year.

This guidance, updated in December 2020 and endorsed by RCPCH, has been produced to inform all healthcare professionals of best practice around the use and prescribing of valproate. It supports them to navigate situations that could arise as a result of prescribing valproate to women during childbea...

We have carefully reviewed this court ruling, which addresses the consent of children and young people to the use of puberty suppressing drugs as part of the treatment of gender dysphoria. We consider that the ruling should not have implications for the general ethical or legal framework for childre...

Russell has heard from many members with concerns for at-risk and vulnerable children in this period, and we're now seeking your insights. He also welcomes the UK government's recent announcement about obesity and junk food advertising, but we need to understand how people's lives are and see the de...

Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.

RCPCH is launching a new data collection and reporting tool to track the impact of COVID-19 on child health services. Dr Jay and Professor Bishop explain why it is so important to capture changes to services during this period.

The overall rates of smoking among UK adults and young people have declined in recent decades. Legislation around the consumption, sale and advertisement of cigarettes has become tighter, and wide-reaching public health campaigns have taken effect.

The RCPCH has today published State of Child Health 2020, the largest ever compilation of data on the health of babies, children and young people across all four UK nations. The report shows that for many measures of children’s health and wellbeing, progress has stalled, or is in reverse – something...

NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.

Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.